{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1110.50",
  "meta": {
    "versionId": "20",
    "lastUpdated": "2022-02-19T01:06:51.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50",
  "version": "20220219",
  "name": "Rivaroxaban for VTE Prophylaxis",
  "status": "active",
  "date": "2022-02-19T01:06:51-05:00",
  "publisher": "TJC EH Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "1114198",
            "display": "rivaroxaban 10 MG Oral Tablet"
          },
          {
            "code": "1232082",
            "display": "rivaroxaban 15 MG Oral Tablet"
          },
          {
            "code": "1232086",
            "display": "rivaroxaban 20 MG Oral Tablet"
          },
          {
            "code": "1549682",
            "display": "{42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivaroxaban 20 MG Oral Tablet) } Pack"
          },
          {
            "code": "2059015",
            "display": "rivaroxaban 2.5 MG Oral Tablet"
          },
          {
            "code": "2588062",
            "display": "rivaroxaban 155 MG Granules for Oral Suspension"
          }
        ]
      }
    ]
  }
}